MOTS-c is a mitochondrial-derived peptide, meaning it is encoded within mitochondrial DNA rather than the cell nucleus. It has been studied for roles in metabolism and exercise physiology.

What does research suggest about MOTS-c?

Most evidence comes from cell and animal studies, where MOTS-c is discussed as a metabolic regulator, possibly through AMPK activation. Rodent research has reported effects on insulin sensitivity, but human evidence remains limited and largely observational.

Is MOTS-c approved or safe?

MOTS-c is not an approved medicine and holds research-chemical status. Human safety data is limited and its long-term profile is unknown, so no safety claims can be made.

What are the side effects of MOTS-c?

There is not enough human data to characterize a reliable side-effect profile. The long-term effects are unknown, and research-market material is unverified in quality and purity.

MOTS-c is generally sold only as a research chemical and is not authorized as a medicine for human use. Its legal status varies by jurisdiction, and it is not approved for general consumer use.

Why is MOTS-c researched?

Scientists study MOTS-c to understand how mitochondria signal to the rest of the body and influence metabolism, endurance, and aging. It represents a novel class of peptides, which makes it of interest for basic research.

Why is MOTS-c described as a "mitochondrial-derived peptide" — what does that actually mean?

Most peptides are encoded by genes in the cell nucleus, but MOTS-c is encoded within mitochondrial DNA (specifically a short open reading frame inside the 12S rRNA region). That origin is why it is grouped with a small family of "mitochondrial-derived peptides" and why much of the research interest centers on cellular energy metabolism. This is background biology, not a health claim.

How is MOTS-c different from more familiar metabolic peptides like the GLP-1 drugs?

They are very different in evidence and status. GLP-1 receptor agonists are approved medicines backed by large controlled human trials. MOTS-c, by contrast, has mostly preclinical (cell and rodent) evidence and no regulatory approval as a medicine. Grouping them together as "metabolic peptides" can be misleading, because one category is a studied drug class and the other is an early-stage research compound.

Is the excitement around MOTS-c based on human results or mostly lab findings?

A common misconception is that the metabolic and exercise-related findings come from established human trials. In reality the bulk of published data is mechanistic work in cells and rodents. Human data is limited and largely observational, so any framing that treats early lab results as proven human benefits gets ahead of the evidence.

Where can I buy MOTS-c and compare vendors?

Use the vendor comparison on this page. It shows only checked, product-specific links and identifies vendor claims, independent documentation and affiliate relationships separately. Availability and legal status can vary by country.

Metabolic

Buy MOTS-c – Vendors, Prices, Testing and Evidence

Buy MOTS-c

Also known as: Mitochondrial ORF of the 12S rRNA type-c

Evidence grade C — Early / Preclinical

Short answer

A mitochondrial-derived peptide discussed for metabolic effects. Mostly preclinical evidence.

Where can you buy MOTS-c?

Crystal Peptides. The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.

What is known?

MOTS-c is a peptide encoded in mitochondrial DNA, studied for roles in metabolism and exercise physiology.

What is not established?

Limited; mostly observational and mechanistic.

Safety

Human safety data is limited; research-market material is unverified.

Regulatory status

Not an approved medicine. Research chemical status.

Not medical advice. This educational reference is not diagnosis, treatment, prescribing, dosing or emergency guidance. Consult a qualified professional before making health-related decisions.

Vendor comparison

Buy MOTS-c: compare vendors

The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.

Vendor	Product	Documentation	Shipping	Checked	Action
Crystal Peptides Code PEPTIDES10 −10% · discount code details Sponsored	MOTS-c research product	Vendor-supplied data COA stated as available Not independently documented	Europe See the localized country store	Jul 18, 2026	View at vendor

Crystal Peptides

MOTS-c research product

Code PEPTIDES10 −10% · discount code details

What is it?

MOTS-c is a peptide encoded in mitochondrial DNA, studied for roles in metabolism and exercise physiology.

Research and evidence

MOTS-c (mitochondrial ORF of the 12S rRNA type-c) is a small peptide encoded not in the cell nucleus but within mitochondrial DNA, placing it in an unusual class of molecules known as mitochondrial-derived peptides. Since its discovery, it has drawn research interest for its apparent role in cellular metabolism and exercise physiology. In laboratory and animal models, MOTS-c has been described as a metabolic regulator, and much of the mechanistic discussion centers on its proposed activation of AMPK, an enzyme that acts as a master sensor of cellular energy balance. It is important to understand from the outset that MOTS-c is not an approved medicine. It carries research-chemical status only, and material sold on the research market is unverified in quality and purity.

The reason MOTS-c is studied comes down to metabolism, endurance, and the broader question of how mitochondria communicate with the rest of the body. Rodent studies have reported effects on insulin sensitivity and metabolic function, and the peptide is frequently discussed in the context of exercise adaptation and aging biology. These are genuinely interesting preclinical signals, but they should not be mistaken for proven human benefits. This is where an honest reading of the evidence matters most: the strongest data for MOTS-c comes from cell-based and animal research, not from controlled clinical trials. Its overall evidence rating is graded low, reflecting how much remains unestablished.

In humans, the evidence for MOTS-c is limited and largely observational or mechanistic rather than the product of large, well-controlled clinical trials. Human safety data is correspondingly sparse, and the long-term profile of taking MOTS-c is simply unknown. Because it has not been approved by any major regulator as a therapeutic agent and exists in a research-chemical gray zone, there is no standardized manufacturing oversight, dosing framework, or safety monitoring behind consumer-facing products. This reference page summarizes what the science currently suggests so that readers can understand MOTS-c accurately; it is educational in nature and is not medical advice, a recommendation, or a protocol. Anyone weighing questions about metabolic health should speak with a qualified healthcare professional.

Evidence grade: C

Limited; mostly observational and mechanistic. Rodent studies report effects on insulin sensitivity and metabolism.

Human evidence

Limited; mostly observational and mechanistic.

Animal and preclinical evidence

Rodent studies report effects on insulin sensitivity and metabolism.

Proposed mechanisms

Discussed AMPK activation
Proposed metabolic-regulation roles

Safety concerns and known side effects

Human safety data is limited; research-market material is unverified.

Unknown long-term profile

Regulatory status

Not an approved medicine. Research chemical status.

MOTS-c research timeline

2015
MOTS-c is first described in the scientific literature as a peptide encoded within the mitochondrial 12S rRNA region, one of a small family of mitochondrial-derived peptides.
2015-late 2010s
Early rodent and cell studies report associations with AMPK activation, insulin sensitivity, and metabolic regulation, establishing the mechanistic hypotheses still discussed today.
late 2010s
Researchers begin exploring MOTS-c in the context of exercise physiology and aging, with several preclinical papers proposing roles in metabolic stress responses.
early 2020s
Small human observational and mechanistic reports appear (for example measuring circulating levels), but rigorous controlled clinical trials in humans remain scarce.
as of the mid-2020s
MOTS-c has no regulatory approval as a medicine anywhere; material sold in the research-chemical market is unapproved and unverified, and long-term human safety data does not exist.

Frequently asked questions about MOTS-c

What is MOTS-c?: MOTS-c is a mitochondrial-derived peptide, meaning it is encoded within mitochondrial DNA rather than the cell nucleus. It has been studied for roles in metabolism and exercise physiology.
What does research suggest about MOTS-c?: Most evidence comes from cell and animal studies, where MOTS-c is discussed as a metabolic regulator, possibly through AMPK activation. Rodent research has reported effects on insulin sensitivity, but human evidence remains limited and largely observational.
Is MOTS-c approved or safe?: MOTS-c is not an approved medicine and holds research-chemical status. Human safety data is limited and its long-term profile is unknown, so no safety claims can be made.
What are the side effects of MOTS-c?: There is not enough human data to characterize a reliable side-effect profile. The long-term effects are unknown, and research-market material is unverified in quality and purity.
Is MOTS-c legal?: MOTS-c is generally sold only as a research chemical and is not authorized as a medicine for human use. Its legal status varies by jurisdiction, and it is not approved for general consumer use.
Why is MOTS-c researched?: Scientists study MOTS-c to understand how mitochondria signal to the rest of the body and influence metabolism, endurance, and aging. It represents a novel class of peptides, which makes it of interest for basic research.
Why is MOTS-c described as a "mitochondrial-derived peptide" — what does that actually mean?: Most peptides are encoded by genes in the cell nucleus, but MOTS-c is encoded within mitochondrial DNA (specifically a short open reading frame inside the 12S rRNA region). That origin is why it is grouped with a small family of "mitochondrial-derived peptides" and why much of the research interest centers on cellular energy metabolism. This is background biology, not a health claim.
How is MOTS-c different from more familiar metabolic peptides like the GLP-1 drugs?: They are very different in evidence and status. GLP-1 receptor agonists are approved medicines backed by large controlled human trials. MOTS-c, by contrast, has mostly preclinical (cell and rodent) evidence and no regulatory approval as a medicine. Grouping them together as "metabolic peptides" can be misleading, because one category is a studied drug class and the other is an early-stage research compound.
Is the excitement around MOTS-c based on human results or mostly lab findings?: A common misconception is that the metabolic and exercise-related findings come from established human trials. In reality the bulk of published data is mechanistic work in cells and rodents. Human data is limited and largely observational, so any framing that treats early lab results as proven human benefits gets ahead of the evidence.
Where can I buy MOTS-c and compare vendors?: Use the vendor comparison on this page. It shows only checked, product-specific links and identifies vendor claims, independent documentation and affiliate relationships separately. Availability and legal status can vary by country.

Common discussion areas

MetabolismEndurance

Compare MOTS-c

MOTS-c vs SS-31 (Elamipretide)

Sources

Editorial review and transparency

Written by: peptides.cx Editorial Team
Scientific reviewer: No named medical reviewer is currently assigned
Last editorial review: June 1, 2026
Last vendor check: July 18, 2026
Review method: Source review, claim verification, vendor-data separation and regulatory-context review.
Commercial disclosure and conflicts: Vendor relationships do not determine evidence or safety ratings. No named reviewer conflict is recorded because no named reviewer is assigned.

Editorial policy →Evidence grade →Vendor methodology →

Related on peptides.cx

Library →Vendor quality checklist →Safety →Affiliate code: PEPTIDES10